Masataka Majima Selected Research

Sodium

8/2020	Prostaglandin E receptor EP4 stimulates lymphangiogenesis to promote mucosal healing during DSS-induced colitis.
3/2009	An ATP-sensitive potassium channel blocker suppresses sodium-induced hypertension through increased secretion of urinary kallikrein.
2/2003	The renal kallikrein-kinin system: its role as a safety valve for excess sodium intake, and its attenuation as a possible etiologic factor in salt-sensitive hypertension.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Masataka Majima Research Topics

Disease

27	Neoplasms (Cancer) 04/2024 - 03/2002
10	Neoplasm Metastasis (Metastasis) 01/2020 - 06/2002
9	Inflammation (Inflammations) 10/2023 - 12/2002
9	Wounds and Injuries (Trauma) 09/2022 - 10/2006
7	Hypertension (High Blood Pressure) 01/2014 - 11/2002
6	Ischemia 01/2020 - 01/2010
6	Ulcer 03/2019 - 01/2008
5	Endometriosis 10/2023 - 02/2011
5	Stomach Ulcer (Gastric Ulcer) 01/2022 - 01/2008
5	Fibrosis (Cirrhosis) 09/2019 - 11/2006
4	Colitis 08/2020 - 09/2002
4	Lewis Lung Carcinoma 02/2014 - 10/2003
3	Lymphedema (Milroy Disease) 10/2023 - 09/2011
3	Necrosis 12/2020 - 02/2012
3	Ureteral Obstruction 01/2019 - 03/2015
3	Endotoxemia 10/2008 - 01/2004
2	Colorectal Neoplasms (Colorectal Cancer) 04/2024 - 01/2003
2	Body Weight (Weight, Body) 01/2024 - 06/2006
2	Obesity 01/2024 - 01/2022
2	Edema (Dropsy) 10/2023 - 05/2003
2	Hepatic Veno-Occlusive Disease (Disease, Hepatic Veno-Occlusive) 07/2021 - 10/2019
2	Prostatic Neoplasms (Prostate Cancer) 01/2020 - 02/2013
2	Hepatitis 01/2018 - 04/2016
2	Reperfusion Injury 01/2018 - 08/2013
2	Lung Neoplasms (Lung Cancer) 12/2016 - 02/2014
2	Pain (Aches) 04/2011 - 02/2008
2	Sarcoma 180 08/2004 - 06/2002
2	Granuloma 09/2002 - 07/2002

Drug/Important Bio-Agent (IBA)

26	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 04/2024 - 03/2002
16	ProstaglandinsIBA 04/2024 - 12/2002
9	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 02/2014 - 01/2003
8	Vascular Endothelial Growth Factor CIBA 01/2024 - 02/2010
8	Messenger RNA (mRNA)IBA 12/2020 - 11/2008
8	Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA 01/2020 - 11/2002
7	ThromboxanesIBA 10/2023 - 01/2004
6	CytokinesIBA 10/2023 - 04/2004
6	Dinoprostone (PGE2)FDA Link 10/2023 - 12/2009
6	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 12/2020 - 02/2005
6	Prostaglandin-E SynthasesIBA 01/2020 - 12/2009
6	SaltsIBA 01/2014 - 11/2002
6	KininsIBA 01/2014 - 01/2002
6	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 02/2012 - 09/2002
5	Prostaglandin E Receptors (Prostaglandin E Receptor)IBA 08/2020 - 10/2006
5	Vascular Endothelial Growth Factor Receptor-1 (fms-Like Tyrosine Kinase)IBA 08/2020 - 03/2014
5	Calcitonin Gene-Related PeptideIBA 01/2020 - 01/2008
5	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 09/2019 - 09/2013
5	Neutralizing AntibodiesIBA 03/2014 - 10/2003
5	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 02/2012 - 01/2004
5	BradykininIBA 03/2009 - 01/2002
4	Vascular Endothelial Growth Factor Receptor-3 (Flt 4)IBA 11/2017 - 02/2010
4	Celecoxib (Celebrex)FDA Link 03/2015 - 02/2010
4	Acetic Acid (Vinegar)FDA LinkGeneric 03/2014 - 01/2008
4	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 02/2014 - 10/2003
4	Tissue Kallikreins (Tissue Kallikrein)IBA 01/2014 - 07/2002
4	Type 1 Angiotensin ReceptorIBA 02/2013 - 06/2002
4	2,5-dichloro-4-bromophenol (B 2)IBA 03/2009 - 01/2002
3	SodiumIBA 08/2020 - 02/2003
3	Proteins (Proteins, Gene)FDA Link 03/2019 - 11/2008
3	Leukotriene B4 Receptors (Leukotriene B4 Receptor)IBA 01/2019 - 08/2013
3	Angiotensin IIIBA 09/2017 - 02/2005
3	calcitonin gene-related peptide (8-37)IBA 04/2017 - 07/2008
3	Thromboxane Receptors (Thromboxane Receptor)IBA 07/2015 - 09/2004
3	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 03/2015 - 12/2002
3	Kallikreins (Kallikrein)IBA 01/2014 - 02/2003
3	Prostaglandins EIBA 09/2011 - 02/2010
3	Kininogens (Kininogen)IBA 01/2010 - 09/2002
3	N- (2- cyclohexyloxy- 4- nitrophenyl)methanesulfonamideIBA 12/2009 - 11/2002
3	FR 173657IBA 03/2009 - 03/2002
2	CholesterolIBA 01/2024 - 09/2004
2	Triglycerides (Triacylglycerol)IBA 01/2024 - 09/2004
2	Arachidonic Acid (Vitamin F)IBA 10/2023 - 10/2023
2	Alanine Transaminase (SGPT)IBA 12/2020 - 10/2019
2	Matrix Metalloproteinases (MMPs)IBA 12/2020 - 12/2016
2	Dextrans (Dextran)FDA Link 08/2020 - 04/2017
2	CXC ChemokinesIBA 01/2020 - 03/2014
2	Transforming Growth Factors (Transforming Growth Factor)IBA 09/2019 - 11/2010
2	Dextran SulfateIBA 03/2019 - 09/2002
2	Concanavalin AIBA 01/2018 - 04/2016
2	CollagenIBA 09/2017 - 05/2003
2	Vascular Endothelial Growth Factor DIBA 01/2016 - 05/2011
2	matrigelIBA 02/2014 - 05/2011
2	ebelactone BIBA 01/2014 - 01/2010
2	PotassiumIBA 01/2014 - 01/2006
2	Antihypertensive Agents (Antihypertensives)IBA 01/2014 - 01/2010
2	KATP ChannelsIBA 01/2014 - 03/2009
2	Leukotriene B4IBA 08/2013 - 07/2008
2	P-SelectinIBA 02/2013 - 04/2012
2	Interleukin-6 (Interleukin 6)IBA 02/2012 - 11/2008
2	Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA 05/2011 - 11/2010
2	Prostaglandin Receptors (Prostaglandin Receptor)IBA 05/2009 - 10/2006
2	candesartan cilexetil (Amias)FDA Link 02/2009 - 06/2002
2	AngiotensinsIBA 02/2009 - 09/2002
2	mofezolacIBA 10/2003 - 12/2002
2	Indomethacin (Indometacin)FDA LinkGeneric 12/2002 - 01/2002
1	Dietary Fats (Dietary Fat)IBA 01/2024
1	Glucose (Dextrose)FDA LinkGeneric 01/2024

Therapy/Procedure

4	Ligation 01/2016 - 01/2002
3	Therapeutics 01/2018 - 02/2009
2	Intravenous Injections 01/2020 - 05/2003
2	Oral Administration 02/2014 - 03/2002